The Scientist

Postdoc Portrait: Kun Bu Bridges AI and Statistics for Reliable Data Insights

University of South Florida postdoctoral researcher Kun Bu develops advanced AI and statistical frameworks to extract clear, ...

Syngenis banks $4M pre-float to power AI-driven biotech platform

Perth biotech Syngenis Labs has banked an oversubscribed $4M pre-IPO raise to expand its AI-powered RNA platform and strengthen domestic genetic medicine capability.

Low-cost genome sequencing approach is powering genetics research on mental illness and many other studies

For researchers on the hunt for the genetic roots of disease, the cost of deep whole-genome sequencing makes it challenging ...

JonBenet Ramsey mystery reignited by lab scandal that adds pressure to unleash DNA help dad is ‘begging’ for

John Ramsey says forensic genetic genealogy could finally name his daughter's killer as Boulder police confirm the CBI DNA ...

DNA leads to arrest in 38-year-cold case murder of woman

Willie J. Carpenter, 68, thought he had gotten away with murder and lived as a highly visible member of his local church for ...

Reed Jobs would rather talk about curing cancer than his last name

When we last sat down with Jobs at TechCrunch Disrupt nearly three years ago, his firm Yosemite was brand new and biotech was ...

Ribosome-based gene circuit lets cells read six signals and trigger responses

The molecular machinery that normally builds proteins inside cells has now taken on a new role as a "switch." A research team ...
Medscape

New Wearable Ultrasound Pacemaker Works Outside the Body

A noninvasive ultrasound device restored heart rhythm in animal models and engineered human heart cells, paving the way for ...

Apertura and NIH institutes to test gene therapy for NPC1

Apertura has entered a cooperative research and development agreement (CRADA) with various NIH institutes for a gene therapy ...

Carla Walker Act aims to expand funding for DNA technology in cold cases

Jim Walker, brother of Fort Worth cold case victim Carla Walker, advocates for the Carla Walker Act that would establish ...

Narrow-Moat Ionis Retains Long-Term Growth Potential Despite Phase 3 ATTR-CM Setback

Ionis Pharmaceuticals is a leader in RNA-based therapies. Its spinal muscular atrophy drug Spinraza, marketed by partner Biogen, is the first RNA-based therapy to achieve blockbuster status. The ...